CBD Oil In Hemp Seed Oil (30%)
CBD Oil In Hemp Seed Oil (30%) Black is backordered and will ship as soon as it is back in stock.
CBD oil in hemp seed oil (30%)
Natural THC-free broad spectrum cannabidiol produced in Switzerland
Our CBD oil in hemp seed oil is a natural product of high quality made with broad spectrum cannabidiol (CBD) obtained from certified Swiss hemp, carefully extracted to preserve the most valuable components. The oil is completely free of THC (tetrahydrocannabinol), and each bottle contains a medical pipette for accurate and easy dosage. This CBD oil is suitable for those who want natural products without artificial dyes, pesticides, herbicides, nicotine or chemical residues.
Benefits and effects of CBD oil in hemp seed oil
CBD oil can contribute to a variety of health benefits and has been used to support the body's natural balance and well-being. CBD can seem relieving and soothing and contributes to a healthier skin, and the hemp seed oil in this formulation provides natural omega-3 and omega-6 fatty acids, vitamins, as well as minerals such as Vitamin E. The combination of CBD and hemp seed oil can provide moisture to the skin and help maintain elasticity and reduce dryness. Important: This oil is intended for cosmetic use and application to skin, not for oral use.
Ingredients and content
- Ingredients: Hemp seed oil (omega-3 and omega-6 fatty acids, minerals and vitamin E), CBD oil (3000 mg cannabidiol from the broad spectrum Swiss hemp)
- Laboratory test: 0.0 % THC, completely free of heavy metals, solvents and pesticides.
- Content per bottle: 10 ml of CBD oil, equals about 270 drops.
Manual
Shake the bottle well before use. Apply a few drops in the desired skin area morning and evening, especially on dry or irritated skin. We recommend starting with a low dose, especially if you are new to CBD products. Store the product in a cool, dry place outside direct sunlight to preserve the quality of the oil.
Test results and quality assurance
This product has been thoroughly tested in Switzerland, both for cannabinoid content and microbiological safety. Our strict quality control ensures that the product meets the market's most stringent requirements for purity and texture. All parties of CBD oil are analyzed to document both cannabinoid content, microbiological safety, absence of heavy metals and remaining solvents.
Reservation
Allowed for adults over 18 years. Not suitable for pregnant or breastfeeding. Always consult a doctor before use if you have a medical condition or use prescription medications. This product is for cosmetic use only. Uno Vita does not claim that the product can cure disease or have other medical effects. CBD cosmetics can be beneficial for dry and irritated skin.
Freedom of speech and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like. We do this with reference to national and international laws on freedom of speech, including:
- The UN World Declaration of Human Rights (1948): Article 19 ensures the right to freedom of opinion and freedom of speech, including the freedom to receive and disseminate information without regard to boundaries.
- The International Convention on Civil and Political Rights (1966): Article 19 emphasizes the right to freedom of speech and the freedom to apply, receive and communicate information and ideas through various media.
- Norwegian Constitution Section 100: Ensures freedom of speech, with certain restrictions on the sake of children's protection, privacy, public order and security.
- US First Amendment: Protects freedom of speech against state intervention, providing one of the strongest protections for free expression.
Uno Vita reserves the right to freedom of opinion and freedom of speech in line with these principles.
Relevant references:
- Huestis, M. A. (2007). Human cannabinoid pharmacokinetics.
- Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
- Ashton, C. H. (2001). Pharmacology and effects of cannabis: a brief review.
- Mechoulam, R., & Parker, L. A. (2013). The Endocannabinoid System and the Brain.
- Russo, E. B. (2011). Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects.
- Pertwee, R. G. (2006). Cannabinoid Pharmacology: The First 66 Years.
- Schicho, R., & Storr, M. (2012). Cannabis Finds Its Way Into Treatment of Crohn's Disease.
- Pamplona, F. A., et al. (2018). The Anti-Inflammatory Properties of Cannabidiol (CBD).
- Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep: A Large Case Series.
- McPartland, J. M., et al. (2015). Are cannabidiol and Δ9 -tastrahydrocannabivarin negative modulators of the endocannabinoid system?
- Zuardi, A. W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
- Pisanti, S., et al. (2017). Cannabidiol: State of the Art and New Challenges for Therapeutic Applications.